Reading Time: 3 minutes Whilst the vast majority of MND research happens in the lab, there is also an increasing amount of research activity looking into how best to
Reading Time: 2 minutes In their official press release published on 21 November 2017, Cytokinetics Inc. announced that they will not be continuing work on tirasemtiv after disappointing results
Reading Time: 3 minutes As I settle into my role as the Research Programmes and Partnerships Manager with the MND Association, I would like to take the opportunity to
Reading Time: 3 minutes At last year’s Airlie House workshop to develop new ALS/MND Clinical Trial Guidelines the focus was, of course, on MND, but there was also important input
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Research we fund
Lighthouse Project shines a beacon on HERVs and their role in ALS
Reading Time: 3 minutes There is recent evidence to suggest that Human Endogenous Retroviruses (HERVs) may be involved in amyotrophic lateral sclerosis (ALS). HERV-K has been directly linked to
Reading Time: 4 minutes Conferences and symposia are a crucial part of the research world – not only for the amount of knowledge that is communicated to large audiences
Reading Time: 4 minutes In April 2016, Dr Jackie Mitchell gave a talk at the Regional Conference in Gatwick to explain the aims of her three year MND Association
Reading Time: 3 minutes This blog is a fabricated story inspired by the current knowledge of MND. Today, we wake to news that Mr Motor Neuron (one of the
Reading Time: 4 minutes In April this year MND clinician-researchers Professors Martin Turner and Kevin Talbot at the University of Oxford organised an information day about the rare, inherited
Reading Time: 2 minutes We are delighted to announce that Dr Arpan Mehta has been appointed as our latest Lady Edith Wolfson Fellow, jointly funded by the MND Association